2008 Summer Meeting
Achieving Optimal Glycemic Control
Track: Quality Standards
Program Code:109-L01
Date: 9 June 2008
Time: Monday, June 9, 2008
Location:603 - Level 6MEETING PLANNING ASSOCIATE:
Stuart Haines, PharmD, BCPS, Professor and Vice Chair for Education, University of Maryland School of Pharmacy
| Dr. Haines is Professor and Vice Chair for Education in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy and a Clinical Associate Professor in Medicine at the UM School of Medicine. His direct patient care responsibilities include serving as a clinical specialist at the Joslin Diabetes Center at University Medicine and the Baltimore VA Medical Center where he provides medication therapy management services and smoking cessation counseling. He served on the Steering Committee for the National Diabetes Education Program (NDEP) for 5 years (2001-2006) and is currently the immediate Past-President of the American College of Clinical Pharmacy.
Dr. Haines’ research interests include medication use behavior, diabetes management, cardiovascular disease prevention, smoking cessation, and evaluation of instructional methods.
Dr. Haines earned his B.S. in Pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Pharm.D. from the University of Texas at Austin. He completed a Pharmacy Practice Residency at the Brigham and Women’s Hospital in Boston as well as a Primary Care Residency at the University of Texas Health Science Center in San Antonio. He is a Board Certified Pharmacotherapy Specialist and Board Certified in Advanced Diabetes Management. He was elected a Distinguished Practitioner in the National Academies of Practice in 2006.
|
MODERATOR:
Stuart Haines, PharmD, BCPS, Professor and Vice Chair for Education, University of Maryland School of Pharmacy
| Dr. Haines is Professor and Vice Chair for Education in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy and a Clinical Associate Professor in Medicine at the UM School of Medicine. His direct patient care responsibilities include serving as a clinical specialist at the Joslin Diabetes Center at University Medicine and the Baltimore VA Medical Center where he provides medication therapy management services and smoking cessation counseling. He served on the Steering Committee for the National Diabetes Education Program (NDEP) for 5 years (2001-2006) and is currently the immediate Past-President of the American College of Clinical Pharmacy.
Dr. Haines’ research interests include medication use behavior, diabetes management, cardiovascular disease prevention, smoking cessation, and evaluation of instructional methods.
Dr. Haines earned his B.S. in Pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Pharm.D. from the University of Texas at Austin. He completed a Pharmacy Practice Residency at the Brigham and Women’s Hospital in Boston as well as a Primary Care Residency at the University of Texas Health Science Center in San Antonio. He is a Board Certified Pharmacotherapy Specialist and Board Certified in Advanced Diabetes Management. He was elected a Distinguished Practitioner in the National Academies of Practice in 2006.
|
PRESENTER(S):
Stuart Haines, PharmD, BCPS, Professor and Vice Chair for Education, University of Maryland School of Pharmacy
| Dr. Haines is Professor and Vice Chair for Education in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy and a Clinical Associate Professor in Medicine at the UM School of Medicine. His direct patient care responsibilities include serving as a clinical specialist at the Joslin Diabetes Center at University Medicine and the Baltimore VA Medical Center where he provides medication therapy management services and smoking cessation counseling. He served on the Steering Committee for the National Diabetes Education Program (NDEP) for 5 years (2001-2006) and is currently the immediate Past-President of the American College of Clinical Pharmacy.
Dr. Haines’ research interests include medication use behavior, diabetes management, cardiovascular disease prevention, smoking cessation, and evaluation of instructional methods.
Dr. Haines earned his B.S. in Pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Pharm.D. from the University of Texas at Austin. He completed a Pharmacy Practice Residency at the Brigham and Women’s Hospital in Boston as well as a Primary Care Residency at the University of Texas Health Science Center in San Antonio. He is a Board Certified Pharmacotherapy Specialist and Board Certified in Advanced Diabetes Management. He was elected a Distinguished Practitioner in the National Academies of Practice in 2006.
|
Paul Szumita, Clinical Pharmacy Supervisor, Brigham and Women's Hospital
| Paul M. Szumita, Pharm.D., BCPS, is Clinical Pharmacy Practice Manager at Brigham and Women’s Hospital (BWH) in Boston, Massachusetts. In this role, he is responsible for directing and managing the optimization of drug therapy by identifying, resolving, and preventing drug-related problems and improving therapeutic outcomes. Previously, Dr. Szumita worked as a clinical specialist in critical care at BWH. He is board-certified as a pharmacotherapy specialist.
Paul is also an Adjunct Assistant Professor of Pharmacy Critical Care at Northeastern University in Boston, where he earned a Doctor of Pharmacy Degree. He helps coordinate 13 clinical rotations at BWH, training more than 100 Doctor of Pharmacy students each year. He also serves as the clinical preceptor for the medical intensive care unit.
In February 2004, Dr. Szumita was appointed secretary of the Diabetes Subcommittee of BWH’s Pharmacy and Therapeutics Committee. Since then, the subcommittee has been involved in several important projects pertaining to inpatient glycemic control, including research on intravenous insulin protocols, implementation and education related to intravenous insulin protocols, subcutaneous insulin order protocols, transition from intravenous to subcutaneous insulin protocols, creating hospital guidelines for management of critically ill patients, and implementation of insulin devices. He has published on the topic of barriers to glucose control in the intensive care unit and treatment and prevention of hyperglycemia in hospitalized patients.
|
Dawn Fuke, PharmD, BCPS, Clinical Pharmacy Specialist, Primary Care, Providence Physician Division
| Dawn C. Fuke, PharmD, BCPS, is a clinical pharmacy specialist with Providence
Physician Division, a community-based primary care health system in Portland, Oregon. Through a successful blend of autonomy and collaboration, pharmacists at Providence Physician Division focus on management and prevention of chronic diseases including diabetes, hypertension, dyslipidemia, cardiovascular disease/heart failure, asthma/COPD, migraine, pain and depression/anxiety. In addition, Dr. Fuke is an affiliate faculty member of the Oregon State University College of Pharmacy, serving as the primary preceptor for Doctor of Pharmacy candidates.
After receiving her Bachelor of Science degree in pharmacy at Oregon State University in Corvallis, Dr. Fuke earned her Doctor of Pharmacy degree at Oregon State University/Oregon Health & Science University in Portland. She then completed an ASHP-accredited specialty residency in primary care with Providence Medical Group. She is a board-certified pharmacotherapy specialist.
Dr. Fuke’s practice interests include, but are not limited to, diabetes treatment and prevention, cardiovascular diseases, obesity, and stewardship of resources. She has spoken to pharmacy and medical groups at state and national meetings on the topics of diabetes, weight management, dyslipidemia, hypertension, and stroke prevention. Dr. Fuke served on the board of directors for the Oregon Society of Health System Pharmacists in 2004-2005 as the northern chapter chair, and is currently co-chairing the educational affairs council. She is also active in national organizations to promote pharmacy and the care of people with diabetes. |
Description:
Patients, practitioners, and health care systems are struggling to achieve tight glycemic control, but where does the pharmacist fit in? Many new anti-diabetic medications and monitoring devices have emerged in the past five years and practitioners in a variety of settings have developed protocols to address this growing problem. Find out the latest medications, technologies, and strategies that have been developed to address the needs of patients who have diabetes, pre-diabetes, or transient hyperglycemia. This session was planned in cooperation with the ASHP Quality Initiative.
Learning Objectives:
- Recommend effective medication regimens for patients who have not yet achieved optimal glycemic control.
- Explain how to apply quality standards to develop system-wide medication use policies that will help achieve optimal glycemic control.
- Describe how to monitor therapeutic plans and drug use policies to achieve optimal glycemic control for individual patients and populations of patients.
